Inventor · disambiguated record
Luke W. Ashcraft
Also filed as: ASHCRAFT LUKE · ASHCRAFT LUKE W
32 granted patents·12 pending applications·228 citations·filing 2005–2025
97Inventor score
Top patents by PatentIndex Score
44 records- 0198US11472796B2Cardiac sarcomere inhibitorsCYTOKINETICS INC·Filed 2020·Granted Oct 18, 2022·10 cites·26 claims
- 0296US11919909B2Cardiac sarcomere inhibitorsCYTOKINETICS INC·Filed 2022·Granted Mar 5, 2024·4 cites·19 claims
- 0396US11299479B1Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2020·Granted Apr 12, 2022·8 cites·23 claims
- 0496US10899746B2Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2020·Granted Jan 26, 2021·5 cites·27 claims
- 0595US10836755B2Cardiac sarcomere inhibitorsCYTOKINETICS INC·Filed 2019·Granted Nov 17, 2020·18 cites·51 claims
- 0695US9604965B2Substituted pyridazines as skeletal muscle modulatorsCYTOKINETICS INC·Filed 2015·Granted Mar 28, 2017·20 cites·35 claims
- 0795US9133123B2Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their useASHCRAFT LUKE W·Filed 2011·Granted Sep 15, 2015·24 cites·45 claims
- 0895US8686007B2Certain heterocycles, compositions thereof, and methods for their useASHCRAFT LUKE W·Filed 2012·Granted Apr 1, 2014·15 cites·30 claims
- 0994US11780826B2Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2022·Granted Oct 10, 2023·2 cites·19 claims
- 1094US10076519B2Substituted pyridazines as skeletal muscle modulatorsCYTOKINETICS INC·Filed 2017·Granted Sep 18, 2018·16 cites·28 claims
- 1193US11952381B2Cardiac sarcomere inhibitorsCYTOKINETICS INC·Filed 2022·Granted Apr 9, 2024·2 cites·20 claims
- 1293US10723720B2Bisamide sarcomere activating compounds and uses therofAMGEN INC·Filed 2018·Granted Jul 28, 2020·7 cites·21 claims
- 1393US8969346B2Amino-pyridazine skeletal muscle modulatorsASHCRAFT LUKE W·Filed 2011·Granted Mar 3, 2015·23 cites·51 claims
- 1493US8759380B2Certain heterocycles, compositions thereof, and methods for their useASHCRAFT LUKE W·Filed 2012·Granted Jun 24, 2014·10 cites·44 claims
- 1591US9278962B2Certain heterocycles, compositions thereof, and methods for their useASHCRAFT LUKE W·Filed 2014·Granted Mar 8, 2016·7 cites·33 claims
- 1691US7851484B2Certain chemical entities, compositions, and methodsCYTOKINETICS INC·Filed 2008·Granted Dec 14, 2010·14 cites·35 claims
- 1791US7582668B2Imidazoyl-benzamide anti-cancer agentsCYTOKINETICS INC·Filed 2006·Granted Sep 1, 2009·5 cites·6 claims
- 1890US11414424B2Cardiac sarcomere inhibitorsCYTOKINETICS INC·Filed 2019·Granted Aug 16, 2022·7 cites·57 claims
- 1989US9994528B2Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their useCYTOKINETICS INC·Filed 2015·Granted Jun 12, 2018·5 cites·34 claims
- 2088US10689393B2Tetrahydroisoquinoline derivativesASTELLAS PHARMA INC·Filed 2019·Granted Jun 23, 2020·3 cites·14 claims
- 2187US10259821B2Tetrahydroisoquinoline derivativesASTELLAS PHARMA INC·Filed 2018·Granted Apr 16, 2019·3 cites·14 claims
- 2286US9914741B2Tetrahydroisoquinoline derivativesASTELLAS PHARMA INC·Filed 2017·Granted Mar 13, 2018·3 cites·15 claims
- 2385US12275741B2Cardiac sarcomere inhibitorsCYTOKINETICS INC·Filed 2024·Granted Apr 15, 2025·0 cites·13 claims
- 2485US2025059173A1Cardiac sarcomere inhibitorsCYTOKINETICS INC·Filed 2024·Application pending·0 cites
- 2584US7618981B2Imidazopyridinyl-benzamide anti-cancer agentsCYTOKINETICS INC·Filed 2005·Granted Nov 17, 2009·7 cites·18 claims
- 2683US11479561B2Tetrahydroisoquinoline derivativesCYTOKINETICS INC·Filed 2020·Granted Oct 25, 2022·1 cites·17 claims
- 2783US7989469B2Certain chemical entities, compositions, and methodsCYTOKINETICS INC·Filed 2009·Granted Aug 2, 2011·5 cites·38 claims
- 2883US2024158372A1Bisamide sarcomere activating compounds and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 2980US2023125280A1Tetrahydroisoquinoline derivativesCYTOKINETICS INC·Filed 2022·Application pending·0 cites
- 3079US12286437B2Cardiac sarcomere inhibitorsCYTOKINETICS INC·Filed 2024·Granted Apr 29, 2025·0 cites·20 claims
- 3178US8207340B2Imidazopyridinyl benzamide mitotic kinesin inhibitorsQIAN XIANGPING·Filed 2009·Granted Jun 26, 2012·1 cites·24 claims
- 3278US7795448B2Imidazoyl-benzamide anti-cancer agentsCYTOKINETICS INC·Filed 2005·Granted Sep 14, 2010·3 cites·10 claims
- 3372US2025276976A1Cardiac sarcomere inhibitorsCYTOKINETICS INC·Filed 2025·Application pending·0 cites
- 3468US8163919B2Imidazopyridinyl benzamide mitotic kinesin inhibitorsQIAN XIANGPING·Filed 2009·Granted Apr 24, 2012·0 cites·24 claims
- 3568US2008255182A1Certain chemical entities, compositions, and methodsSMITHKLINE BEECHAM CORP·Filed 2008·Application pending·0 cites
- 3667US8772507B2Imidazole-benzamide anti-cancer agentsQIAN XIANGPING·Filed 2012·Granted Jul 8, 2014·0 cites·19 claims
- 3767US2010069453A1Certain Chemical Entities, Compositions, and MethodsCYTOKINETICS INC·Filed 2009·Application pending·0 cites
- 3866US2009286841A1Certain chemical entities, compositions, and methodsSMITHKLINE BEECHAM CORP·Filed 2009·Application pending·0 cites
- 3964US2012283287A1Certain chemical entities, compositions, and methodsQIAN XIANGPING·Filed 2012·Application pending·0 cites
- 4061US2023116972A1Cd38 modulators and methods of use thereofCYTOKINETICS INC·Filed 2022·Application pending·0 cites
- 4159US2016289211A1Certain heterocycles, compositions thereof, and methods for their useCYTOKINETICS INC·Filed 2016·Application pending·0 cites
- 4257US2022332708A1Sulfonamide compounds as cardiac sarcomere activatorsCYTOKINETICS INC·Filed 2022·Application pending·0 cites
- 4347US7572814B23,5-dibenzoyl-4-phenyl-piperidine anti-cancer compoundsCYTOKINETICS INC·Filed 2006·Granted Aug 11, 2009·0 cites·25 claims
- 4445US2011312975A1Certain chemical entities, compositions and methodsYANG ZHE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Luke W. Ashcraft files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →